Atlas FDA

VNS THERAPY SYSTEM

FDA premarket approval P970003/S111 · decided 2010-08-04

Approval details

PMA number
P970003
Supplement
S111
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol - OSB
Trade name
VNS THERAPY SYSTEM
Generic name
Stimulator, autonomic nerve, implanted for epilepsy
Applicant
LivaNova USA, Inc.
Date received
2010-06-22
Decision date
2010-08-04
Days to decision
43 days
Decision code
APPR
Product code
LYJ
Advisory committee
Neurology
Expedited review
No
Location
Houston, TX
Statement
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Venous Return Cannulae (K250937)LivaNova USA, Inc.2026-03-11
RAP Femoral Venous Cannulae (K250283)LivaNova USA, Inc.2025-07-10
SMARxT Tubing and Connectors (K233702)LivaNova USA, Inc.2024-08-08